MedTrace Logo

Single-dose Escalation Trial of M2ES in Healthy Volunteer

NCT01223924 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2010-10-19

No results posted yet for this study

Summary

This is a randomized double-blinded placebo-controlled，single-dose escalation trial in healthy volunteer.

Conditions

Interventions

OTHER

placebo

placebo

DRUG

M2ES

M2ES IV 7.5mg-90mg

Sponsors & Collaborators

  • Protgen Ltd

    lead INDUSTRY

Principal Investigators

  • Ji JIANG, MD · Perking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-09-30
Completion
2009-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01223924 on ClinicalTrials.gov